Otsuka To Invest ¥7.5 Billion For R&D In Korea
This article was originally published in PharmAsia News
Executive Summary
Japanese drug maker Otsuka Pharmaceutical signed an agreement with South Korea's Ministry of Health, Welfare and Family Affairs and will invest KRW100 billion (¥7.5 billion) over five years for research and development in Korea